Found: 14
Select item for more details and to access through your institution.
Non-neutralizing SARS-CoV-2 N-terminal domain antibodies protect mice against severe disease using Fc-mediated effector functions.
- Published in:
- PLoS Pathogens, 2024, v. 20, n. 6, p. 1, doi. 10.1371/journal.ppat.1011569
- By:
- Publication type:
- Article
Structure and Fc-Effector Function of Rhesusized Variants of Human Anti-HIV-1 IgG1s.
- Published in:
- Frontiers in Immunology, 2022, v. 12, p. 1, doi. 10.3389/fimmu.2021.787603
- By:
- Publication type:
- Article
Polyclonal Broadly Neutralizing Antibody Activity Characterized by CD4 Binding Site and V3-Glycan Antibodies in a Subset of HIV-1 Virus Controllers.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.670561
- By:
- Publication type:
- Article
Multivariate analysis of FcR-mediated NK cell functions identifies unique clustering among humans and rhesus macaques.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1260377
- By:
- Publication type:
- Article
Antibody Fc effector functions and IgG3 associate with decreased HIV-1 risk.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Functional Homology for Antibody-Dependent Phagocytosis Across Humans and Rhesus Macaques.
- Published in:
- Frontiers in Immunology, 2021, v. 12, p. 1, doi. 10.3389/fimmu.2021.678511
- By:
- Publication type:
- Article
Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.
- Published in:
- Nature Communications, 2017, v. 8, n. 6, p. 1, doi. 10.1038/ncomms15711
- By:
- Publication type:
- Article
Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans.
- Published in:
- NPJ Vaccines, 2022, v. 7, n. 1, p. 1, doi. 10.1038/s41541-022-00514-9
- By:
- Publication type:
- Article
Author Correction: Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00307-6
- By:
- Publication type:
- Article
Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.
- Published in:
- NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00307-6
- By:
- Publication type:
- Article
Safety, pharmacokinetics, and immunological activities of multiple intravenous or subcutaneous doses of an anti-HIV monoclonal antibody, VRC01, administered to HIV-uninfected adults: Results of a phase 1 randomized trial.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The triple combination of tenofovir, emtricitabine and efavirenz shows synergistic anti-HIV-1 activity in vitro: a mechanism of action study.
- Published in:
- Retrovirology, 2009, v. 6, p. 1, doi. 10.1186/1742-4690-6-44
- By:
- Publication type:
- Article
Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response.
- Published in:
- PLoS Pathogens, 2023, v. 18, n. 5, p. 1, doi. 10.1371/journal.ppat.1011359
- By:
- Publication type:
- Article